First Time Loading...

Sinovac Biotech Ltd
NASDAQ:SVA

Watchlist Manager
Sinovac Biotech Ltd Logo
Sinovac Biotech Ltd
NASDAQ:SVA
Watchlist
Price: 6.47 USD Market Closed
Updated: May 2, 2024

Sinovac Biotech Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sinovac Biotech Ltd
Cash from Financing Activities Peer Comparison

Comparables:
6160
1801
603392
S
002252
300122

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Sinovac Biotech Ltd
NASDAQ:SVA
Cash from Financing Activities
-$241.4m
CAGR 3-Years
N/A
CAGR 5-Years
-184%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash from Financing Activities
-¥448.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash from Financing Activities
¥2.9B
CAGR 3-Years
-16%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash from Financing Activities
-¥893.3m
CAGR 3-Years
N/A
CAGR 5-Years
-98%
CAGR 10-Years
N/A
S
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Cash from Financing Activities
-¥1.1B
CAGR 3-Years
-164%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash from Financing Activities
-¥2.4B
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
-39%

See Also

What is Sinovac Biotech Ltd's Cash from Financing Activities?
Cash from Financing Activities
-241.4m USD

Based on the financial report for Dec 31, 2022, Sinovac Biotech Ltd's Cash from Financing Activities amounts to -241.4m USD.

What is Sinovac Biotech Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-184%

Over the last year, the Cash from Financing Activities growth was 87%.